Alpha 2.0
Login Register
» Authors » Hasan Khosravi

Hasan Khosravi

Explore the profile of Hasan Khosravi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 153
Followers 0
Related Specialties
Dermatology
Biochemistry
Oncology
Top 10 Co-Authors
Maryam Daneshpazhooh
Joseph C English 3rd
Amir Teimourpour
Kamran Balighi
Autumn Moorhead
Arash Mostaghimi
Caroline Kettering
Sophia Zhang
Fan Di Xia
Timothy Patton
Published In
J Am Acad Dermatol
JAAD Case Rep
Dermatol Online J
J Dtsch Dermatol Ges
J Biol Chem
Affiliations
Soon will be listed here.
Recent Articles
1.
Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men
Behkar A, Garmaroudi G, Nasimi M, Yousefi S, Khosravi H, Kianfar N, et al.
Int J Womens Dermatol . 2022 May; 8(1):e004. PMID: 35620025
Objective: This study aims to determine the quality of life of AIBD patients undergoing systemic treatment while investigating the survey's relationship with various factors. Methods: In this 2-step cross-sectional study,...
2.
Inpatient Teledermatology Improves Diagnostic Accuracy and Management of Leg Ulcers in Hospitalized Patients
Khosravi H, Nekooie B, Moorhead A, English 3rd J
Am J Clin Dermatol . 2021 Aug; 22(5):735-737. PMID: 34453281
No abstract available.
3.
Cutaneous metastatic esophageal adenocarcinoma diagnosed via inpatient teledermatology
Khosravi H, Moesch J, English 3rd J
JAAD Case Rep . 2021 May; 12:51-53. PMID: 34026996
No abstract available.
4.
Drug survival of systemic and biologic monotherapy treatments for pityriasis rubra pilaris: A retrospective observational study
Kettering C, Khosravi H, Ortiz C, English 3rd J
J Am Acad Dermatol . 2021 Apr; 86(5):1142-1143. PMID: 33894320
No abstract available.
5.
Concordance data for inpatient asynchronous eDermatology consultation for immunobullous disease, zoster, and vasculitis
Ortiz C, Khosravi H, Kettering C, Moorhead A, English 3rd J
J Am Acad Dermatol . 2021 Mar; 86(4):918-920. PMID: 33753251
No abstract available.
6.
Real-world experience of adalimumab in the treatment of hidradenitis suppurativa
Khosravi H, Anderson A, Kettering C, Mizes A, Patton T
J Am Acad Dermatol . 2020 Dec; 84(5):1406-1409. PMID: 33316329
No abstract available.
7.
Comparing acne follow-up: teledermatology versus outpatient dermatology visits
Khosravi H, Zhang S, Siripong N, Moorhead A, English Iii J
Dermatol Online J . 2020 Jul; 26(4). PMID: 32621674
The application of teledermatology for evaluating acne patients has yielded comparable therapeutic outcomes with traditional face-to-face evaluation, but follow-up compliance between these modalities is not well-studied. Our objective is to...
8.
Sweet syndrome with pulmonary involvement in a patient with myelodysplastic syndrome
Mizes A, Khosravi H, Bordelon J, Kazlouskaya V, Karunamurthy A, Ho J, et al.
Dermatol Online J . 2020 Jul; 26(3). PMID: 32609450
We report a patient with Sweet syndrome involving the pulmonary system in the context of myelodysplastic syndrome. Although Sweet syndrome may involve a variety of organ systems, the pulmonary system...
9.
Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma
Haitz K, Khosravi H, Lin J, Menge T, Nambudiri V
J Am Acad Dermatol . 2020 Feb; 83(1):189-196. PMID: 32004650
Talimogene laherparepvec (T-VEC) is an oncolytic virus based on herpes simplex virus type 1 approved for intralesional treatment of advanced melanoma. In this article, we review the clinical literature on...
10.
Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States
Khosravi H, Zhang S, Anderson A, Ferris L, Choudhary S, Patton T
J Am Acad Dermatol . 2019 Dec; 82(4):1023-1024. PMID: 31866263
No abstract available.